Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1079) 1079
Book Chapter (16) 16
Publication (7) 7
Dissertation (5) 5
Book Review (1) 1
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
latanoprost (983) 983
science & technology (670) 670
life sciences & biomedicine (651) 651
humans (628) 628
ophthalmology (597) 597
intraocular pressure - drug effects (486) 486
glaucoma (474) 474
female (451) 451
male (448) 448
middle aged (349) 349
prostaglandins f, synthetic - therapeutic use (344) 344
aged (336) 336
glaucoma, open-angle - drug therapy (324) 324
intraocular pressure (280) 280
antihypertensive agents - therapeutic use (266) 266
prostaglandins f, synthetic - administration & dosage (252) 252
prostaglandins f, synthetic - adverse effects (239) 239
biological and medical sciences (236) 236
ocular hypertension - drug therapy (234) 234
medical sciences (231) 231
adult (216) 216
pharmacology. drug treatments (184) 184
antihypertensive agents - adverse effects (175) 175
ophthalmic solutions (175) 175
treatment outcome (174) 174
antihypertensive agents - administration & dosage (168) 168
glaucoma - drug therapy (161) 161
aged, 80 and over (156) 156
timolol (151) 151
bimatoprost (144) 144
travoprost (141) 141
eye (138) 138
eye diseases (132) 132
genetic structures (131) 131
prospective studies (129) 129
sense organs (128) 128
drug therapy, combination (127) 127
ocular hypertension (127) 127
animals (122) 122
double-blind method (120) 120
prostaglandins f, synthetic - pharmacology (117) 117
timolol - therapeutic use (113) 113
cloprostenol - analogs & derivatives (109) 109
tonometry, ocular (106) 106
pharmacology & pharmacy (102) 102
glaucoma, open-angle - physiopathology (100) 100
administration, topical (98) 98
abridged index medicus (94) 94
medicine & public health (92) 92
prostaglandins (91) 91
timolol - administration & dosage (87) 87
open-angle glaucoma (79) 79
drug therapy (75) 75
hypertension (74) 74
ocular hypertension - physiopathology (72) 72
cross-over studies (65) 65
antihypertensive agents - pharmacology (64) 64
adrenergic beta-antagonists - therapeutic use (63) 63
timolol - adverse effects (61) 61
ophthalmic drugs (58) 58
follow-up studies (57) 57
dorzolamide (55) 55
drug administration schedule (55) 55
dose-response relationship, drug (53) 53
drug combinations (53) 53
glaucoma and intraocular pressure (52) 52
internal medicine (51) 51
safety (51) 51
analysis (50) 50
brimonidine (49) 49
cloprostenol - therapeutic use (48) 48
sulfonamides - therapeutic use (48) 48
care and treatment (47) 47
pharmacology/toxicology (46) 46
prostaglandin (45) 45
drug toxicity and drugs side effects treatment (44) 44
ophthalmic solutions - administration & dosage (44) 44
patients (44) 44
thiophenes - therapeutic use (44) 44
medicine, research & experimental (43) 43
research & experimental medicine (43) 43
retrospective studies (43) 43
brimonidine tartrate (42) 42
original research (42) 42
toxicity: eye (41) 41
time factors (39) 39
cloprostenol - adverse effects (38) 38
glaucoma - physiopathology (37) 37
visual acuity (37) 37
intraocular pressure - physiology (35) 35
adrenergic beta-antagonists - administration & dosage (34) 34
amides (34) 34
dinoprost - analogs & derivatives (34) 34
adolescent (33) 33
lipids - therapeutic use (33) 33
sulfonamides - administration & dosage (33) 33
drug synergism (31) 31
research (31) 31
studies (31) 31
surgery (31) 31
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1059) 1059
Japanese (16) 16
Spanish (13) 13
German (11) 11
French (10) 10
Russian (5) 5
Portuguese (4) 4
Slovak (4) 4
Turkish (4) 4
Czech (3) 3
Korean (3) 3
Polish (2) 2
Chinese (1) 1
Dutch (1) 1
Italian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Efficacy of the combination of carteolol hydrochloride + latanoprost in the treatment of glaucoma and ocular hypertension
by Soares, Rebecca Russ and Razeghinejad, M Reza
Expert opinion on pharmacotherapy, ISSN 1465-6566, 10/2018, Volume 19, Issue 15, pp. 1731 - 1738
Adherence | Glaucoma | beta-adrenergic antagonis | Prostaglandin analogues | Ocular hypertension | tolerability | Carteolol | fixed-combination carteolol-latanoprost | Latanoprost | Antihypertensive Agents - pharmacology | Latanoprost - pharmacology | Carteolol - therapeutic use | Humans | Carteolol - pharmacology | Glaucoma - drug therapy | Latanoprost - therapeutic use | Male | Treatment Outcome | Antihypertensive Agents - therapeutic use | Ocular Hypertension - drug therapy | Drug Therapy, Combination - methods | Latanoprost - pharmacokinetics | Carteolol - pharmacokinetics | Female | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Latanoprost, a balanced prostaglandin
by Martinez-de-la-Casa, Jose M and Donde, Shaantanu and Wierzbowska, Joanna
Expert review of ophthalmology, ISSN 1746-9899, 01/2019, Volume 14, Issue 1, pp. 61 - 72
Glaucoma | latanoprost | prostaglandin F | latanoprost‒timolol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Uveitis-induced Refractory Ocular Hypotony Managed with High-dose Latanoprost
by Ghassemi, Fariba and Reza Niyousha, Mohammad and Hassanpoor, Narges and Khojasteh, Hassan
Journal of ophthalmic & vision research, ISSN 2008-2010, 07/2020, Volume 15, Issue 3, pp. 408 - 411
latanoprost | hypotony | uveitis | inflammation | behcet
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The Glaucoma Italian Pediatric Study (GIPSy): Three-year Results
by Quaranta, Luciano and Biagioli, Elena and Biagioli, Elena and Riva, Ivano and Riva, Ivano and Galli, Francesca and Galli, Francesca and Poli, Davide and Poli, Davide and Rulli, Eliana and Rulli, Eliana and Katsanos, Andreas and Longo, Antonio and Longo, Antonio and Uva, Maurizio G and Uva, Maurizio G and Oddone, Francesco and Oddone, Francesco and Torri, Valter and Torri, Valter and Weinreb, Robert N and Weinreb, Robert N
Journal of glaucoma, ISSN 1057-0829, 10/2018, Volume 27, Issue 10, pp. 856 - 863
dorzolamide | latanoprost | glaucoma surgery | pediatric glaucoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension
by Sinha, Sapna and Lee, Daniel and Kolomeyer, Natasha N and Myers, Jonathan S and Razeghinejad, Reza
Expert opinion on pharmacotherapy, ISSN 1465-6566, 01/2020, Volume 21, Issue 1, pp. 39 - 45
Adherence | fixed-combination netarsudil (AR-1324)-latanoprost | latanoprost | ocular hypertension | prostaglandin analogues | glaucoma | tolerability | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Latanoprost - administration & dosage | Intraocular Pressure - drug effects | Humans | beta-Alanine - administration & dosage | Glaucoma - drug therapy | Male | Antihypertensive Agents - therapeutic use | Benzoates - administration & dosage | Ocular Hypertension - drug therapy | Ophthalmic Solutions | Female | beta-Alanine - analogs & derivatives | Drug Combinations | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text 0.005% preservative-free latanoprost induces dry eye-like ocular surface damage via promotion of inflammation in mice
by Yang, Yiran and Huang, Caihong and Lin, Xiang and Wu, Yang and Ouyang, Weijie and Tang, Liying and Ye, Sihao and Wang, Yuhong and Li, Wei and Zhang, Xiaobo and Liu, Zuguo
Investigative ophthalmology & visual science, ISSN 0146-0404, 07/2018, Volume 59, Issue 8, pp. 3375 - 3384
Inflammation | Ocular surface | Dry eye | Latanoprost | Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Inflammation - chemically induced | Inflammation - pathology | Humans | Antihypertensive Agents - administration & dosage | Tears - metabolism | NF-kappa B - metabolism | Epithelium, Corneal - physiology | Occludin - metabolism | Occludin - genetics | Dry Eye Syndromes - pathology | Antihypertensive Agents - toxicity | Inflammation - metabolism | Matrix Metalloproteinase 9 - metabolism | Cornea - drug effects | Matrix Metalloproteinase 9 - genetics | Female | Cornea - pathology | p38 Mitogen-Activated Protein Kinases - metabolism | Zonula Occludens-1 Protein - metabolism | Real-Time Polymerase Chain Reaction | Fluorescent Antibody Technique, Indirect | In Situ Nick-End Labeling | Zonula Occludens-1 Protein - genetics | Latanoprost - administration & dosage | Enzyme-Linked Immunosorbent Assay | Mice, Inbred C57BL | p38 Mitogen-Activated Protein Kinases - genetics | Matrix Metalloproteinase 3 - metabolism | Conjunctivitis - chemically induced | Latanoprost - toxicity | Blotting, Western | Conjunctivitis - pathology | Cornea - metabolism | Preservatives, Pharmaceutical | Animals | NF-kappa B - genetics | Dry Eye Syndromes - metabolism | Conjunctivitis - metabolism | Dry Eye Syndromes - chemically induced | Mice | Matrix Metalloproteinase 3 - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Effect of Topical Prostaglandin F2 alpha Analogs on Selected Oxidative Stress Parameters in the Tear Film
by Sedlak, Lech and Zych, Maria and Wojnar, Weronika and Wygledowska-Promienska, Dorota
Medicina (Kaunas, Lithuania), ISSN 1010-660X, 07/2019, Volume 55, Issue 7, p. 366
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Benzalkonium Compounds - therapeutic use | Latanoprost - pharmacology | Prostaglandins F - therapeutic use | Dinoprost - pharmacokinetics | Cross-Sectional Studies | Tears - chemistry | Humans | Oxidative Stress - physiology | Benzalkonium Compounds - pharmacokinetics | Glaucoma - drug therapy | Latanoprost - therapeutic use | Latanoprost - pharmacokinetics | Prostaglandins F - pharmacology | Poland | Prostaglandins F - pharmacokinetics | Benzalkonium Compounds - pharmacology | Dinoprost - therapeutic use | Oxidative Stress - drug effects | Administration, Topical | Dinoprost - pharmacology | Tears - drug effects | Index Medicus | latanoprost | tears | bimatoprost | glaucoma | ocular surface | tafluprost | benzalkonium chloride
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effects of Netarsudil and Latanoprost Alone and in Fixed Combination on Corneal Endothelium and Corneal Thickness: Post-Hoc Analysis of MERCURY-2
by Wisely, C. Ellis and Sheng, Huan and Heah, Theresa and Kim, Terry
Advances in therapy, ISSN 0741-238X, 01/2020, Volume 37, Issue 3, pp. 1114 - 1123
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Hypertension | Glaucoma | Endothelium | Health technology assessment | Original Research | Open-angle glaucoma | Ocular hypertension | Intraocular pressure | Latanoprost | Netarsudil | latanoprost fixed combination
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and-2
by Asrani, Sanjay and Bacharach, Jason and Holland, Edward and McKee, Hayley and Sheng, Huan and Lewis, Richard A and Kopczynski, Casey C and Heah, Theresa
Advances in therapy, ISSN 0741-238X, 04/2020, Volume 37, Issue 4, pp. 1620 - 1631
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Benzoates - adverse effects | beta-Alanine - adverse effects | Benzoates - therapeutic use | Intraocular Pressure - drug effects | Latanoprost - adverse effects | Ophthalmic Solutions - therapeutic use | United States | Humans | Middle Aged | Ophthalmic Solutions - adverse effects | beta-Alanine - therapeutic use | Latanoprost - therapeutic use | Male | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Glaucoma, Open-Angle - drug therapy | Ocular Hypertension - drug therapy | Tonometry, Ocular | Female | Aged | beta-Alanine - analogs & derivatives | United States Food and Drug Administration | Health technology assessment | Glaucoma | Rho kinase inhibitor | Original Research | Fixed-dose combination | Ocular hypertension | Clinical trial | Prostaglandin analogue | Intraocular pressure | Latanoprost | Netarsudil
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial
by Asrani, Sanjay and Robin, Alan L and Serle, Janet B and Lewis, Richard A and Usner, Dale W and Kopczynski, Casey C and Heah, Theresa and Ackerman, Stacey L and Alpern, Louis M and Asrani, Sanjay and Bashford, Kent and Bluestein, Ettaleah C and Boyce, James D and Branch, James D and Brubaker, Jacob W and Christie, William C and Cohen, John S and Collins, Nicole M and Corin, Scott M and Daynes, Todd Ellsworth and Depenbusch, Michael and Dixon, El-Roy and Duzman, Eran and Flowers, Brian E and Flynn, William J and Fong, Raymond and Gira, Joseph P and Goldberg, Damien F and Greene, Brennan and Han, Scott B and Henderson, Thomas T and Jerkins, Gary and Jong, Kevin Y and Katzen, Lawrence B and Khemsara, Vickas and Klugo, Karen L and Kozlovsky, John F and Leonardo, Donna and Liu, Yao and LoBue, Thomas D and Luchs, Jodi Ian and Malhotra, Ranjan P and Mays, Andrew and McLaurin, Eugene B and McMenemy, Matthew G and Modi, Satish and Moroi, Sayoko and Mulaney, Jay and Nagi, Kundandeep and Nicolau, John and Parikh, Mihir and Patel, Jay R and Peplinski, Lee S and Perez, Bernard R and Piltz-Seymour, Jody and Sadri, Ehsan and Saltzmann, Robert M and Schenker, Howard I and Swanic, Matthew J and Tekwani, Navin and Teymoorian, Savak and Thomas, Justus W and Tyson, Farrell C and Vold, Stephen and Weiss, Mark J and Zaman, Fiaz and MERCURY-1 Study Group and Mercury 1 Study Grp
American journal of ophthalmology, ISSN 0002-9394, 11/2019, Volume 207, pp. 248 - 257
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Administration, Ophthalmic | Benzoates - adverse effects | Benzoates - therapeutic use | Intraocular Pressure - drug effects | Latanoprost - adverse effects | Ocular Hypertension - physiopathology | Humans | Middle Aged | Ocular Hypertension - diagnosis | Latanoprost - therapeutic use | Male | rho-Associated Kinases - antagonists & inhibitors | Ocular Hypertension - drug therapy | Ophthalmic Solutions | Tonometry, Ocular | Female | beta-Alanine - analogs & derivatives | beta-Alanine - adverse effects | Double-Blind Method | Glaucoma, Open-Angle - diagnosis | Glaucoma, Open-Angle - physiopathology | beta-Alanine - therapeutic use | Intraocular Pressure - physiology | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Glaucoma, Open-Angle - drug therapy | Aged | Drug Combinations | Hypertension | Glaucoma | Clinical trials | Drug therapy, Combination | Analysis | Diabetic retinopathy | Population | Patient compliance | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Effects of prostaglandin F2α analogues on endothelin-1-induced impairment of rabbit ocular blood flow: Comparison among tafluprost, travoprost, and latanoprost
by Kurashima, Hiroaki and Watabe, Hiroshi and Sato, Noriko and Abe, Sanae and Ishida, Naruhiro and Yoshitomi, Takeshi
Experimental eye research, ISSN 0014-4835, 12/2010, Volume 91, Issue 6, pp. 853 - 859
Tafluprost | ET-1 | Ocular blood flow | Latanoprost | Travoprost
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The Effect of Latanaprost on Intraocular Inflammation and Macular Edema
by Razeghinejad, M. Reza
Ocular immunology and inflammation, ISSN 0927-3948, 02/2019, Volume 27, Issue 2, pp. 181 - 188
Prostaglandin analogs | Macular edema | Intraocular inflammation | Iritis | Latanoprost | Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Macular Edema - etiology | Inflammation - drug therapy | Uveitis - drug therapy | Humans | Macular Edema - drug therapy | Latanoprost - therapeutic use | Antihypertensive Agents - therapeutic use | Uveitis - complications | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Does using topical latanoprost affect subfoveal choroidal thickness?
by Duru, Zeynep and Özsaygılı, Cemal and Ulusoy, Döndü Melek and Armağan Demirtaş, Atılım and Çiçek, Ayşe and Duru, Necati
Cutaneous and ocular toxicology, ISSN 1556-9527, 10/2019, Volume 38, Issue 4, pp. 370 - 374
latanoprost | Choroidal thickness | prostaglandin analogs | EDI-OCT | Toxicology | Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Choroid - diagnostic imaging | Latanoprost - administration & dosage | Latanoprost - adverse effects | Ocular Hypertension - pathology | Tomography, Optical Coherence | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Glaucoma, Open-Angle - pathology | Male | Antihypertensive Agents - adverse effects | Glaucoma, Open-Angle - drug therapy | Ocular Hypertension - drug therapy | Ophthalmic Solutions | Adult | Female | Aged | Administration, Topical | Choroid - pathology | Choroid - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text The Effects of Latanoprost With Benzalkonium Chloride Versus Travoprost With SofZia on the Ocular Surface
by Rahmatnejad, Kamran and Rapuano, Christopher J and Ichhpujani, Parul and Wizov, Sheryl S and Moster, Marlene R and Hark, Lisa A and Katz, L Jay
Eye & contact lens, ISSN 1542-2321, 11/2018, Volume 44 Suppl 2, pp. S93 - S98
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Antihypertensive Agents - pharmacology | Latanoprost - pharmacology | Prospective Studies | Latanoprost - adverse effects | Humans | Middle Aged | Tears - metabolism | Latanoprost - therapeutic use | Male | Travoprost - pharmacology | Preservatives, Pharmaceutical - pharmacology | Conjunctiva - pathology | Cornea - drug effects | Aged, 80 and over | Adult | Female | Preservatives, Pharmaceutical - therapeutic use | Benzalkonium Compounds - pharmacology | Cornea - pathology | Travoprost - adverse effects | Benzalkonium Compounds - therapeutic use | Preservatives, Pharmaceutical - adverse effects | Intraocular Pressure | Benzalkonium Compounds - adverse effects | Glaucoma - drug therapy | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Conjunctiva - drug effects | Aged | Glaucoma - pathology | Travoprost - therapeutic use | Therapeutics, Ophthalmological | Dosage and administration | Health aspects | Patient outcomes | Methods | Travoprost | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights